Technology & Telecommunication Services » Software | Senseonics Holdings Inc.

Senseonics Holdings Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2015
2016
2017
2018
Net Income before Extraordinaries
30,691.00
43,930.00
59,101.00
93,971
Depreciation, Depletion & Amortization
118.00
155.00
227.00
270
Other Funds
-
1,004.00
80.00
9,606
Funds from Operations
28,295.00
40,672.00
54,330.00
84,095
Changes in Working Capital
2,830.00
2,656.00
1,409.00
6,676
Net Operating Cash Flow
25,465.00
38,016.00
55,739.00
90,771
Capital Expenditures
202.00
479.00
345.00
Purchase/Sale of Investments
-
7,291.00
12,881.00
Net Investing Cash Flow
202.00
7,770.00
13,226.00
Issuance/Reduction of Debt, Net
-
10,000.00
4,896.00
Net Financing Cash Flow
10,683.00
54,894.00
72,068.00
Net Change in Cash
14,984.00
9,108.00
3,103.00
Free Cash Flow
25,667.00
38,495.00
56,084.00
Change in Capital Stock
10,683.00
45,898.00
67,252.00

About Senseonics Holdings

View Profile
Address
20451 Seneca Meadows Parkway
Germantown Maryland 20876
United States
Employees -
Website http://www.senseonics.com
Updated 07/08/2019
Senseonics Holdings, Inc. is a medical technology company, which engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its products include eversense sensor, eversense smart transmitter, eversence mobile application, and eversense data management system. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.